Spontaneous rectus sheath hematomas: when to restart anticoagulation?

Area of Science:

• Internal Medicine
• Cardiology
• Hematology

Background:

• Spontaneous rectus sheath hematoma (RSH) is a rare condition often associated with anticoagulation.
• Optimal timing for resuming anticoagulation after RSH diagnosis is not well-established.

Purpose of the Study:

• To determine the safety and optimal timing for resuming anticoagulation in patients diagnosed with spontaneous RSH.
• To analyze complication rates associated with anticoagulation resumption after RSH.

Main Methods:

• Retrospective review of 156 patients with spontaneous RSH diagnosed between 1997 and 2012.
• Analysis of anticoagulation medication types, need for intervention, and timing of resumption.
• Evaluation of patient outcomes, including complications such as hemorrhage, thrombosis, renal failure, and death.

Main Results:

• Anticoagulation was resumed in 62% of patients, with a median re-initiation time of 4 days post-diagnosis.
• Intervention for hemorrhage control was required in only 19% of patients.
• The overall complication rate was 19%, with acute renal failure and death being the most common (5% each). Thrombotic events occurred in 3% of patients.

Conclusions:

• Hemorrhage control interventions are often unnecessary for spontaneous RSH.
• Anticoagulation can generally be safely resumed by day 4 after RSH diagnosis.
• The higher incidence of thrombotic versus bleeding complications suggests that anticoagulation may be withheld for an extended period, necessitating further investigation into optimal resumption protocols.